401906-14-7

Basic information

• Product Name: L-Phenylalanine, N-(2,6-dichlorobenzoyl)-4-nitro-
• CAS NO: 401906-14-7
• Molecular Formula: C16H12Cl2N2O5
• Molecular Weight: 383.188
• Mol File: 401906-14-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: L-Phenylalanine, N-(2,6-dichlorobenzoyl)-4-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, N-(2,6-dichlorobenzoyl)-4-nitro-(401906-14-7)
• EPA Substance Registry System: L-Phenylalanine, N-(2,6-dichlorobenzoyl)-4-nitro-(401906-14-7)

Safety Data

• Hazardous Substances Data: 401906-14-7(Hazardous Substances Data)

Upstream product

• 949-99-5 4-nitro-3-phenyl-L-alanine 
• 4659-45-4 2,6-Dichlorobenzoyl chloride 

Downstream Products

• 917885-98-4 C₆H₈O₇*C₃₀H₃₀Cl₂N₄O₅ 
• 917886-02-3 C₄H₆O₆*C₃₀H₃₀Cl₂N₄O₅ 
• 917886-01-2 C₄H₆O₆*C₃₀H₃₀Cl₂N₄O₅ 
• 917885-99-5 C₄H₄O₄*C₃₀H₃₀Cl₂N₄O₅ 
• 917886-04-5 C₂HF₃O₂*C₂₇H₂₄Cl₂N₄O₅ 
• 917885-95-1 C₃₀H₃₀Cl₂N₄O₅*H₃O₄P 
• 917885-97-3 C₃₀H₃₀Cl₂N₄O₅*H₂O₄S 
• 917886-00-1 C₂H₄O₂*C₃₀H₃₀Cl₂N₄O₅ 
• 917885-94-0 BrH*C₃₀H₃₀Cl₂N₄O₅ 
• 917885-96-2 Nα-(2,6-dichlorobenzoyl)-4-{1-methyl-6-(N-methylamino-methyl)-quinazoline-2,4[1H,3H]-dion-3-yl}-L-phenylalanine isopropyl ester hydrochloride 
• 857870-34-9 N-(2,6-dichlorobenzoyl)-4-(6-carboxy-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3-(2H)-yl)-L-phenylalanine isopropylester 
• 857870-16-7 4-[6-(chloromethyl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3(2H)-yl]-N-(2,6-dichlorobenzoyl)-L-phenylalanine isopropyl ester 
• 857870-32-7 N-(2,6-dichlorobenzoyl)-4-(6-iodo-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3-(2H)-yl)-L-phenylalanine isopropylester 
• 857870-30-5 N-(2,6-dichlorobenzoyl)-4-(6-iodo-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3-(2H)-yl)-L-phenylalanine isopropylester 

Relevant articles and documents

PROCESS FOR PRODUCTION OF PHENYLALANINE DERIVATIVES HAVING QUINAZOLINEDIONE SKELETONS AND INTERMEDIATES FOR THE PRODUCTION

A method for preparing a phenylalanine derivative having a quinazoline-dione ring represented by the following formula (1) or a pharmaceutically acceptable salt thereof, comprising the following steps (a), (b) and (c): (a) reacting an acyl phenylalanine d